Pharmaceutical industry regulation

Sen. Chuck Grassley, R-Iowa, chairman of the Senate Finance Committee, attends a hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Jacquelyn Martin)
February 26, 2019 - 10:43 am
WASHINGTON (AP) — Senators grilled CEOs of seven major drug companies on Tuesday over high prescription drug prices that are a drain on Medicare and Medicaid and a burden to millions of Americans. The extraordinary public accounting was a sign that Congress and the White House are moving toward...
Read More
FILE - In this July 10, 2018 file photo, bottles of prescription medicines ride on a conveyor belt at a pharmacy warehouse in Florence, N.J. According to a report released on Tuesday, Jan. 8, 2018, annual spending by the U.S. health industry on ads and promotions has reached $30 billion. That includes advertisements for prescription drugs that were shown 5 million times on TV and elsewhere in 2016. That’s a huge increase in 20 years and just part of broad health industry efforts to promote drugs, devices, lab tests and even new hospitals. (AP Photo/Julio Cortez, File)
January 08, 2019 - 2:29 pm
Ads for prescription drugs appeared 5 million times in just one year, capping a recent surge in U.S. medical marketing, a new analysis found. The advertisements for various medicines showed up on TV, newspapers, online sites and elsewhere in 2016. Their numbers soared over 20 years as part of broad...
Read More
FILE - In this Oct. 17, 2018, file photo a depiction of a cannabis bud drops from the ceiling at Leafly's countdown party in Toronto as midnight passes and marks the first day of the legalization of cannabis across Canada. The last year was a 12-month champagne toast for the legal marijuana industry as the global market exploded and cannabis pushed its way further into the financial and cultural mainstream. Canada ushered in broad legalization, U.S. drug regulators approved the first cannabis-based drug and investors pumped in billions of dollars. (Chris Young/The Canadian Press via AP, File)
December 27, 2018 - 3:44 pm
PORTLAND, Ore. (AP) — The last year was a 12-month champagne toast for the legal marijuana industry as the global market exploded and cannabis pushed its way further into the financial and cultural mainstream. Liberal California became the largest legal U.S. marketplace, conservative Utah and...
Read More
FILE - In this Oct. 17, 2018, file photo a depiction of a cannabis bud drops from the ceiling at Leafly's countdown party in Toronto as midnight passes and marks the first day of the legalization of cannabis across Canada. The last year was a 12-month champagne toast for the legal marijuana industry as the global market exploded and cannabis pushed its way further into the financial and cultural mainstream. Canada ushered in broad legalization, U.S. drug regulators approved the first cannabis-based drug and investors pumped in billions of dollars. (Chris Young/The Canadian Press via AP, File)
December 27, 2018 - 5:27 am
PORTLAND, Ore. (AP) — The last year was a 12-month champagne toast for the legal marijuana industry as the global market exploded and cannabis pushed its way further into the financial and cultural mainstream. Liberal California became the largest legal U.S. marketplace, while conservative Utah and...
Read More
August 30, 2018 - 10:27 pm
SACRAMENTO, Calif. (AP) — A federal judge has dismissed a lawsuit seeking to block a California law requiring pharmaceutical companies to give advance notice before big price increases. U.S. District Judge Morrison England Jr., ruled Thursday in Sacramento that the Pharmaceutical Research and...
Read More
June 04, 2018 - 3:00 am
BERLIN (AP) — German pharmaceutical company Bayer AG said Monday that it plans to complete its purchase of U.S. seed and weed-killer maker Monsanto Co. this week after receiving all the required approvals from regulators. Bayer said in a statement that it plans to complete the acquisition on...
Read More
June 04, 2018 - 2:42 am
BERLIN (AP) — German pharmaceutical company Bayer AG says it plans to complete its purchase of U.S. seed and weed-killer maker Monsanto Co. this week after receiving all the required approvals from regulators. Bayer said in a statement that it plans to complete the acquisition on Thursday. The deal...
Read More
George Barrett, left, executive chairman of the board, Cardinal Health, Inc., Dr. Joseph Mastandrea, chairman of the board, Miami-Luken, Inc., John Hammergren, chairman, president, and CEO, McKesson Corporation, J. Christopher Smith, former president and CEO, H.D. Smith Wholesale Drug Company, and Steven Collis, chairman, president, and CEO, AmerisourceBergen Corporation, are sworn in before they testify during a hearing of the Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, about the opioid epidemic, on Capitol Hill, Tuesday, May 8, 2018 in Washington. (AP Photo/Alex Brandon)
May 08, 2018 - 12:15 pm
WASHINGTON (AP) — Lawmakers of both parties accused wholesale pharmaceutical distributors on Tuesday of missing signs of suspicious activity that resulted in hundreds of millions of prescription opioid pills being shipped to West Virginia, a state disproportionately ravaged by deaths caused by the...
Read More
FILE - This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. The FDA receives about 1,000 requests to use experimental drugs for “compassionate use” each year and approves more than 99 percent of them, according to agency figures. The process usually takes about four days, although in emergency cases regulators can grant permission immediately over the phone. (AP Photo/Andrew Harnik, File)
March 22, 2018 - 1:14 pm
WASHINGTON (AP) — The idea is a political crowd-pleaser with a catchy slogan: giving desperately ill patients the "right to try" experimental medicines. Lawmakers in the U.S. House of Representatives on Wednesday became the latest group of politicians to back the effort, sending a bill to the...
Read More
In this Nov. 29, 2017 file photo, Alex Azar, President Donald Trump's nominee to become Secretary of Health and Human Services, arrives to testify before the Senate Health, Education, Labor and Pensions Committee confirmation hearing on Capitol Hill in Washington. The Senate has confirmed Azar as President Donald Trump’s second health secretary. (AP Photo/Carolyn Kaster, File)
January 24, 2018 - 3:57 pm
WASHINGTON (AP) — President Donald Trump's second health secretary won Senate approval Wednesday, clearing the way for Alex Azar to take over a sprawling department shaken by his predecessor's early exit. The GOP-majority Senate voted 55-43, largely along party lines, to confirm the former drug...
Read More

Pages